UK Drug Co. Settles For $19.6M Over False Safety Claims

By Katryna Perera

A New York federal judge has granted final approval to a $19.6 million settlement between investors and U.K.-based consumer goods and health conglomerate Reckitt Benckiser Group PLC, resolving claims that it defrauded shareholders by not disclosing that regulators determined that its drug used to treat narcotics dependency was more susceptible to accidental child consumption.

 Order attached | Read full article » | Save to favorites »